| Financial Year |
March 31 2023 |
| Monetary Funds |
15,543,264.41 |
| Held-for-trading Financial Assets |
1,685,776.25 |
| Notes Receivable |
-- |
| Accounts Receivable |
51,823,992.18 |
| Advances to Suppliers |
10,055,279.79 |
| Other Receivables |
12,271,718.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,000,070.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,162,577.43 |
| Total Current Assets |
161,542,678.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,232,350.93 |
| Investment Properties |
-- |
| Fixed Assetes |
15,469,612.74 |
| Under-construction Projects |
896,653.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,783.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,427,773.65 |
| Deferred Income Tax Assets |
23,166,148.89 |
| Other Non-Current Assets |
70,277,233.00 |
| Sub-Total of Non-Current Assets |
370,990,215.49 |
| Total Assets |
532,532,893.94 |
| Short-Term Loans |
140,312,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
79,276,547.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,782,155.24 |
| Taxes Payable |
5,866,134.02 |
| Interest Payable |
-- |
| Dividend Payable |
1,482,795.03 |
| Other payables |
140,042,401.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,589,621.64 |
| Other Current Liabilities |
720,252.38 |
| Sub-Total of Current Liabilities |
413,820,400.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
753,159.66 |
| Deferred Income Tax Liabilities |
4,300,520.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,862,309.90 |
| Total Liabilities |
496,682,710.32 |
| Paid-In Capital(Or Share Stock) |
806,230,192.00 |
| Capital Surplus |
1,873,520,755.14 |
| Surplus Reserve |
95,002,296.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,648,066,222.20 |
| Minority Stockholder's Interest |
-23,169,064.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
59,019,248.39 |
| Owner's Equity（Stockholder's Equity） |
35,850,183.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
532,532,893.94 |
